High-level, multiresistant enterococci associated with systemic disease: A report of two cases

Annals of Saudi Medicine

Volumn 16, Issue 6, 1996, Pages 682-685

  Qadri, S M Hussain ^a   Ellis, Michael E ^a   Al Rabiah, Fahad ^a   Ernst, Peter ^a   Ingemansson, Stig ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; BUSULFAN; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; METRONIDAZOLE; NETILMICIN; TETRACYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CASE REPORT; CLINICAL FEATURE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; FATALITY; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0030499368     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.1996.682     Document Type: Article

References (21)

1. Thiercelin ME. Sur un diplocoque saprophyte de intestine susceptible de devenir pathogene. C R Soc Biol 1989; 5:269-271.
2. Schleifer KH, Kilpper-Balz R. Transfer of Streptococcus faecalis and Streptococcus faecium to the genus Enterococcus nom. rev. as Enterococcus faecalis comb. nov. and Enterococcus faecium comb. nov. Intl J Syst Bacteriol 1984; 34:31-34.
3. Fontana R, Aldegheri M, Ligozzi M, Lopez H, Sucari A, Satta G. Over production of a low-affinity penicillin-binding protein and high-level ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1994; 38:1980-1983.
4. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991 ; (Suppl. 3B):72S-75S.
5. Kaufhold A, Podbielski A, Horaud TH, Ferrieri P. Identical genes confer high-level resistance to gentamicin upon Enterococcus faecalis, Enterococcus faecium, and Streptococcus agalactiae. Antimicrob Agents Chemother 1992;36:1215-1218.
6. Kaplan AH, Gilligan PH, Facklam RR. Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol 1988; 26:1216-1218.
7. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319:157-161.
8. Qadri, SMH, Qunibi WY, Al-Ballaa SR, Kadhi Y, Burdette JM. Vancomycin-resistant Enterococcus: a case report and review of literature. Ann Saudi Med 1993; 13:289-293.
9. Murray PR, Baron MJ, Pfaller MA, Tenover FC, Yolken RH. Manual of Clinical Laboratory. 6th ed. Washington, DC: American Society for Microbiology, 1995.
10. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard M2-A5. National Committee for Clinical Laboratory Standards, Villanova, PA 1993.
11. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa 1993.
12. Kaplan AH, Gilligan PH, Facklam RR. Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol 1988; 26:1216-1218.
13. Montecalvo MA, Horowitz H, Gedris C et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994; 38:1363-1367.
14. Handwerger S, Perlman DC, Altarac D, McAuliffe V. Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. Clin Infect Dis 1992; 14:655-661.
15. Cercenado E, Eliopoulos GM, Wennersten CB, Moellering RC Jr. Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci. Antimicrob Agents Chemother 1992; 36:2201-2203.
16. Landman D, Mobaraki NK, Quale JM. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin. Antimicrob Agents Chemother 1993; 37:1904-1908.
17. Uttley AHC, George RC, Naidoo J, et al. High level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infec 1989;103:173-181.
18. Mekonen ET, Noskin GA, Hacek DM, Peterson LR. Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium. Microbial Drug Res 1995;1:249-253.
19. Qadri SMH, Ueno Y, Abumustafa FM, Halim M. In vitro activity of Synercid™ (Quinupristin/dalfopristin, RP59500) against gram-positive clinical isolates. Chemother 1996; (in-press).
20. Brandt CM, Rouse MS, Laue NW, Stratton CW, Wilson WR, Steckelberg JM. Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell-wall-active agents. J Infect Dis 1996; 173:909-913.
21. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995; 105-113.